Both stroke subtypes were characterized by higher plasma C3a levels compared to the respective control group at both evaluation time points (P<0.05 to P<0.001), although C3a levels in the acute phase were markedly higher than at three months after stroke (P<0.001) (Fig. 1B). The gene discussed is C3; the disease is stroke disorder.